StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) stock

ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

Estrella Immunopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Estrella Immunopharma

Estrella Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Estrella Immunopharma figures

See a number that looks wrong?